Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)

BACKGROUND: Bacterial prostatitis (BP) is a common condition accounting responsible for about 5-10% of all prostatitis cases; chronic bacterial prostatitis (CBP) classified as type II, are less common but is a condition that significantly hampers the quality of life, (QoL) because not only is it a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Busetto, Gian Maria, Giovannone, Riccardo, Ferro, Matteo, Tricarico, Stefano, Del Giudice, Francesco, Matei, Deliu Victor, De Cobelli, Ottavio, Gentile, Vincenzo, De Berardinis, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108969/
https://www.ncbi.nlm.nih.gov/pubmed/25038794
http://dx.doi.org/10.1186/1471-2490-14-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108969/
https://www.ncbi.nlm.nih.gov/pubmed/25038794
http://dx.doi.org/10.1186/1471-2490-14-53

Ejemplares similares